25-hydroxycholesterol has been researched along with Congenital Zika Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aliyari, R; Au, C; Buth, JE; Cheng, G; Dai, X; Deng, YQ; Dong, HL; Du, P; Fan, J; Gong, D; Hong, S; Huang, XY; Li, C; Li, L; Li, XF; Liu, P; Liu, Y; Lu, N; Ma, F; Novitch, BG; Qin, CF; Qin, FX; Sun, R; Tian, M; Vishlaghi, N; Wang, S; Watanabe, M; Xu, Z; Ye, Q; Zhang, B; Zhang, NN; Zhao, H | 1 |
| Caracciolo, I; Crovella, S; D'Agaro, P; Gratton, R; Tricarico, PM | 1 |
2 other study(ies) available for 25-hydroxycholesterol and Congenital Zika Syndrome
| Article | Year |
|---|---|
25-Hydroxycholesterol Protects Host against Zika Virus Infection and Its Associated Microcephaly in a Mouse Model.
Topics: Animals; Antiviral Agents; Brain; Disease Models, Animal; Fluorescent Antibody Technique; Humans; Hydroxycholesterols; Macaca mulatta; Mice; Microcephaly; Microscopy, Confocal; Virus Internalization; Zika Virus; Zika Virus Infection | 2017 |
25-hydroxycholesterol reduces inflammation, viral load and cell death in ZIKV-infected U-87 MG glial cell line.
Topics: Cell Death; Cell Line, Tumor; Cytokines; Humans; Hydroxycholesterols; Inflammasomes; Inflammation; Interleukin-1beta; Macrophages; Neuroglia; Viral Load; Zika Virus; Zika Virus Infection | 2019 |